These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20800522)

  • 1. Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spots specimens after newborn screening.
    Vladutiu GD
    Mol Genet Metab; 2010; 101(2-3):93-4. PubMed ID: 20800522
    [No Abstract]   [Full Text] [Related]  

  • 2. The investigation of factors influencing the measurement of thyroid stimulating hormone in dried blood spots on filter paper.
    Chen X; Wu G; Song Z; Zhou H; Zhou C; Yang C; Wang W
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():147-9. PubMed ID: 15906721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening.
    Therrell BL; Hannon WH; Bailey DB; Goldman EB; Monaco J; Norgaard-Pedersen B; Terry SF; Johnson A; Howell RR
    Genet Med; 2011 Jul; 13(7):621-4. PubMed ID: 21602691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous diagnostic method for phenylketonuria and galactosemia from dried blood spots using high-performance liquid chromatography-pulsed amperometric detection.
    Kim NH; Jeong JS; Kwon HJ; Lee YM; Yoon HR; Lee KR; Hong SP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jul; 878(21):1860-4. PubMed ID: 20494631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Storage and use of residual dried blood spots.
    Webster D; ;
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():49-51. PubMed ID: 15906694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fate of newborn screening blood spots.
    Grody WW; Howell RR
    Pediatr Res; 2010 Mar; 67(3):237. PubMed ID: 20154576
    [No Abstract]   [Full Text] [Related]  

  • 7. Waiving informed consent in newborn screening research: balancing social value and respect.
    Tarini BA; Burke W; Scott CR; Wilfond BS
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):23-30. PubMed ID: 18200521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doctors explore research potential of blood samples from newborns.
    Roehr B
    BMJ; 2009 Sep; 339():b3984. PubMed ID: 19786491
    [No Abstract]   [Full Text] [Related]  

  • 9. Storage and use of residual dried blood spots from state newborn screening programs.
    Olney RS; Moore CA; Ojodu JA; Lindegren ML; Hannon WH
    J Pediatr; 2006 May; 148(5):618-22. PubMed ID: 16737872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioethical considerations in neonatal screening: Japanese experiences.
    Matsuda I
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():46-8. PubMed ID: 15906693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update: newborn screening for endocrinopathies.
    Pass KA; Neto EC
    Endocrinol Metab Clin North Am; 2009 Dec; 38(4):827-37. PubMed ID: 19944295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tandem mass spectrometric identification of dextrose markers in dried-blood spots from infants receiving total parenteral nutrition.
    Chace DH; De Jesús VR; Lim TH; Hannon WH; Spitzer AR
    Clin Chim Acta; 2010 Nov; 411(21-22):1806-16. PubMed ID: 20707991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Method for the quantification of underivatized amino acids on dry blood spots from newborn screening by HPLC-ESI-MS/MS.
    Zoppa M; Gallo L; Zacchello F; Giordano G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):267-73. PubMed ID: 16388997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False positive newborn screening results are not always benign.
    Morrison DR; Clayton EW
    Public Health Genomics; 2011; 14(3):173-7. PubMed ID: 21178328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal birth parameters of positive newborns at PKU screening as predictors of false-positive and positive results at recall-testing.
    Zaffanello M; Zamboni G; Maffeis C; Tatò L
    J Med Screen; 2003; 10(4):181-3. PubMed ID: 14738655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False-positive results in expanded newborn screening.
    Hanley WB
    Pediatrics; 2007 Feb; 119(2):414-5; author reply 415. PubMed ID: 17272638
    [No Abstract]   [Full Text] [Related]  

  • 17. Stable-isotope dilution measurement of isovalerylglycine by tandem mass spectrometry in newborn screening for isovaleric acidemia.
    Shigematsu Y; Hata I; Tanaka Y
    Clin Chim Acta; 2007; 386(1-2):82-6. PubMed ID: 17850781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The call from the newborn screening laboratory: frustration in the afternoon.
    Rhead WJ; Irons M
    Pediatr Clin North Am; 2004 Jun; 51(3):803-18, xii. PubMed ID: 15157599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Michigan BioTrust for Health: public support for using residual dried blood spot samples for health research.
    Duquette D; Langbo C; Bach J; Kleyn M
    Public Health Genomics; 2012; 15(3-4):146-55. PubMed ID: 22488457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for cystic fibrosis in dried blood spots of newborns.
    Audrézet MP; Costes B; Ghanem N; Fanen P; Verlingue C; Morin JF; Mercier B; Goossens M; Férec C
    Mol Cell Probes; 1993 Dec; 7(6):497-502. PubMed ID: 8145780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.